CARLSBAD, Calif., March 15, 2016 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced today the addition of Troy Woolley to its senior leadership team.
Mr. Woolley, who joined the company in September 2015 as Senior Director of Marketing, has been promoted to Vice President of Marketing, Spine Hardware. In addition to Mr. Woolley’s current responsibilities for Spine Hardware Marketing, he will also provide leadership and direction for the Global Marketing Services team supporting surgeon education, sales training, and branding. Mr. Woolley’s key priorities will include the timely launch and commercialization of new Spine Hardware products and developing cohesive corporate branding across both the Spine Hardware and Orthobiologics portfolios. Mr. Woolley brings over 20 years of product development and marketing experience and expertise to this new role.
Mr. Woolley will report directly to Keith Valentine, SeaSpine’s President and Chief Executive Officer.
“We are pleased to be strengthening our Senior Leadership Team through the new role for Troy, as his knowledge and experience are critically important to our goal of launching 8 to 10 new and next generation products and product line extensions each year,” said Keith Valentine, President and Chief Executive Officer of SeaSpine. “I look forward to Troy’s leadership and focus on our innovation pipeline and collaboration with the Spine Hardware product development team as we continue to grow and meet our strategic objectives.”
SeaSpine is a global medical technology company focused on the design, development and commercialization of surgical solutions for the treatment of patients suffering from spinal disorders. SeaSpine has a comprehensive portfolio of orthobiologics and spinal fusion hardware solutions to meet the varying combinations of products that neurosurgeons and orthopedic spine surgeons need to perform fusion procedures on the lumbar, thoracic and cervical spine. SeaSpine’s orthobiologics products consist of a broad range of advanced and traditional bone graft substitutes that are designed to improve bone fusion rates following a wide range of orthopedic surgeries, including spine, hip, and extremities procedures. SeaSpine’s spinal fusion hardware portfolio consists of an extensive line of products to facilitate spinal fusion in minimally invasive surgery (MIS), complex spine, deformity and degenerative procedures. Expertise in both orthobiologic sciences and spinal fusion hardware product development allows SeaSpine to offer our surgeon customers a differentiated portfolio and a complete solution to meet their fusion requirements. SeaSpine currently markets its products in the United States and in over 30 countries worldwide.
Investor Relations Contact Lynn Pieper Lewis (415) 309-5999 email@example.com
Source:SeaSpine Holdings corporation